Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated:  4/1/2013
Clinical Research Facility
mi
from
Jacksonville, FL
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated: 4/1/2013
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated:  4/1/2013
Clinical Research Facility
mi
from
Augusta, GA
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated: 4/1/2013
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated:  4/1/2013
Clinical Research Facility
mi
from
New Orleans, LA
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated: 4/1/2013
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated:  4/1/2013
Clinical Research Facility
mi
from
Portland, OR
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated: 4/1/2013
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated:  4/1/2013
Clinical Research Facility
mi
from
Greenville, SC
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated: 4/1/2013
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated:  4/1/2013
Clinical Research Facility
mi
from
Houston, TX
The EVICEL® Gastrointestinal Study
A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques
Status: Enrolling
Updated: 4/1/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Glendale, CA
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Danbury, CT
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Miami, FL
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated:  4/3/2013
Clinical Research Facility
mi
from
Duncansville, PA
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
A Phase 1, Randomized, Double-Blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects, in Subjects With Active Ulcerative Colitis, and in Subjects With Active Crohn's Disease.
Status: Enrolling
Updated: 4/3/2013
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Preferred Research Partners, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
TRIMED Clinical Trials
mi
from
Corona, CA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
TRIMED Clinical Trials
mi
from
Corona, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Digestive Care Associates
mi
from
San Carlos, CA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Digestive Care Associates
mi
from
San Carlos, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of California - San Francisco
mi
from
San Francisco, CA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Rocky Mountain Gastroenterology Associates
mi
from
Lakewood, CO
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Rocky Mountain Gastroenterology Associates
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Clinical Research of West Florida
mi
from
Clearwater, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Gastroenterology Group of Naples
mi
from
Naples, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Shafran Gastroenterology Center
mi
from
Winter Park, FL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Chicago Hospital Medical Center
mi
from
Chicago, IL
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Chicago Hospital Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Louisville School of Medicine
mi
from
Louisville, KY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Louisville School of Medicine
mi
from
Louisville, KY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Endoscopic Microsurgery Associates
mi
from
Towson, MD
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Endoscopic Microsurgery Associates
mi
from
Towson, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
MedRACS
mi
from
Quincy, MA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
MedRACS
mi
from
Quincy, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Center for Digestive Health
mi
from
Troy, MI
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Center for Digestive Health
mi
from
Troy, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Digestive Health Center
mi
from
Ocean Springs, MS
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Digestive Health Center
mi
from
Ocean Springs, MS
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
St. Louis Center for Clinical Research
mi
from
St. Louis, MO
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
St. Louis Center for Clinical Research
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Long Island Clinical Research Associates, LLP
mi
from
Great Neck, NY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Long Island Clinical Research Associates, LLP
mi
from
Great Neck, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
NY Scientific CORP
mi
from
Hollis, NY
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
NY Scientific CORP
mi
from
Hollis, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Pmg Research Of Salisbury
mi
from
Salisbury, NC
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Pmg Research Of Salisbury
mi
from
Salisbury, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Ohio Gastroenterology and Liver
mi
from
Cincinnati, OH
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Ohio Gastroenterology and Liver
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
Advanced Research Institute
mi
from
Ogden, UT
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
Advanced Research Institute
mi
from
Ogden, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Utah
mi
from
Salt Lake City, UT
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated:  4/9/2013
University of Washington Medical Center
mi
from
Seattle, WA
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Daikenchuto (TU-100) in Subjects With Moderate Crohn's Disease
Status: Enrolling
Updated: 4/9/2013
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Single-Dose Study of the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency (MK-4618-013)
A Two-Part, Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency
Status: Enrolling
Updated:  4/10/2013
Clinical Research Facility
mi
from
Tampa, FL
A Single-Dose Study of the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency (MK-4618-013)
A Two-Part, Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-4618 in Patients With Hepatic Insufficiency
Status: Enrolling
Updated: 4/10/2013
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  4/11/2013
Clinical Research Facility
mi
from
Miami Gardens, FL
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 4/11/2013
Clinical Research Facility
mi
from
Miami Gardens, FL
Click here to add this to my saved trials
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  4/11/2013
Clinical Research Facility
mi
from
Tampa, FL
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 4/11/2013
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  4/11/2013
Clinical Research Facility
mi
from
Knoxville, TN
Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment
An Open-label, Pharmacokinetic and Tolerability Study of SAR302503 Given as a Single 300 mg Dose in Subjects With Mild and Moderate Hepatic Impairment, and in Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 4/11/2013
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Effective Treatment for Prescription Opioid Abuse
Effective Treatment for Prescription Opioid Abuse
Status: Enrolling
Updated:  4/12/2013
Substance Abuse Treatment Center, University of Vermont
mi
from
Burlington, VT
Effective Treatment for Prescription Opioid Abuse
Effective Treatment for Prescription Opioid Abuse
Status: Enrolling
Updated: 4/12/2013
Substance Abuse Treatment Center, University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Aiyan Diabetes Center
mi
from
Evans, GA
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Aiyan Diabetes Center
mi
from
Evans, GA
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Bellevue Hospital
mi
from
New York, NY
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Elks Wound Center
mi
from
Meridian, ID
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Elks Wound Center
mi
from
Meridian, ID
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Georgetown University Medical Center
mi
from
Washington,
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Lincoln Hospital
mi
from
New York, NY
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Lincoln Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated:  4/16/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
Wound EMR to Decrease Limb Amputations in Persons With Diabetes
Status: Enrolling
Updated: 4/16/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials